Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenue	$ 8,804,000	$ 200,000
Cost of revenue:
Cost of revenue	7,203,000	417,000
Provision for contract losses	6,485,000	0
Total cost of revenue	13,688,000	417,000
Gross loss	(4,884,000)	(217,000)
Operating expenses:
Selling, general, and administrative	30,386,000	3,713,000
Research and development	13,478,000	3,583,000
Total operating expenses	43,864,000	7,296,000
Operating loss	(48,748,000)	(7,513,000)
Interest income (expense), net	634,000	(3,000)
SAFE Instruments remeasurement	(86,907,000)	0
Warrant remeasurement	(6,651,000)	(7,000)
Other (expense) income, net	(517,000)	86,000
Net loss before taxes	(142,189,000)	(7,437,000)
Provision for income taxes	(2,000)	0
Net loss	(142,191,000)	(7,437,000)
Other comprehensive loss, net of taxes
Unrealized losses on available-for-sale securities	(17,000)	0
Cumulative translation adjustment	13,000	0
Total comprehensive loss	$ (142,195,000)	$ (7,437,000)
Loss per share
Loss per share – Basic (in dollars per share)	$ (11.88)	$ (0.93)
Loss per share – Diluted (in dollars per share)	$ (11.88)	$ (0.93)
Weighted average number of shares outstanding – Basic	11,970,550	7,978,512
Weighted average number of shares outstanding – Diluted	11,970,550	7,978,512